BIOLOGY AND BIOTECHNOLOGY
Rocket Pharmaceuticals Updates on FDA-Aligned Trial - RCKT
Rocket Pharmaceuticals updates on its pivotal Phase 2 trial for RP-A501, highlighting key findings from the Danon disease webinar.
USEUROCKET PHARMACEUTICALSROCKET PHARMACEUTICALS INCNASDAQRP A 501 RP A 501